When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 8 Hits
  • Search Condition : Filter (MeSH = Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*)
Species Resource
Mice B6.Cg-Tg(Tec-p210 BCR/ABL1)1Homy(RBRC02339) NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
Human and Animal Cells Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Human and Animal Cells Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
Human and Animal Cells Effect of arsenic trioxide on different cell lines derived from chronic myeloid leukemia.
Human and Animal Cells Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid.
Human and Animal Cells Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1.
Human and Animal Cells K562 Pharmacological inhibition of JAK3 enhances the antitumor activity of imatinib in human chronic myeloid leukemia.
Human and Animal Cells K562(RCB0027) ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells.